Research Papers:
Antibody-based targeting of alternatively spliced tissue factor: a new approach to impede the primary growth and spread of pancreatic ductal adenocarcinoma
PDF | HTML | Supplementary Files | How to cite
Metrics: PDF 1844 views | HTML 2711 views | ?
Abstract
Dusten Unruh1, Betül Ünlü2, Clayton S. Lewis1, Xiaoyang Qi1, Zhengtao Chu1, Robert Sturm1, Ryan Keil1, Syed A. Ahmad1, Timofey Sovershaev3, Mariette Adam4, Patrick Van Dreden4, Barry J. Woodhams5, Divya Ramchandani6, Georg F. Weber6, Janusz W. Rak7, Alisa S. Wolberg8, Nigel Mackman8, Henri H. Versteeg2, Vladimir Y. Bogdanov1
1College of Medicine, University of Cincinnati, Cincinnati, OH, USA
2Leiden University Medical Center, Leiden, The Netherlands
3The Arctic University of Norway, Tromsø, Norway
4Diagnostica Stago R & D, Gennevilliers, France
5Haemacon Ltd, Bromley, UK
6College of Pharmacy, University of Cincinnati, Cincinnati, OH, USA
7McGill University Health Centre, Montreal Children’s Hospital, Montreal, Canada
8University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Correspondence to:
Vladimir Y. Bogdanov, email: [email protected]
Keywords: pancreatic cancer, tissue factor, alternative splicing, β1 integrins, metastasis
Received: August 25, 2015 Accepted: February 13, 2016 Published: March 07, 2016
ABSTRACT
Alternatively spliced Tissue Factor (asTF) is a secreted form of Tissue Factor (TF), the trigger of blood coagulation whose expression levels are heightened in several forms of solid cancer, including pancreatic ductal adenocarcinoma (PDAC). asTF binds to β1 integrins on PDAC cells, whereby it promotes tumor growth, metastatic spread, and monocyte recruitment to the stroma. In this study, we determined if targeting asTF in PDAC would significantly impact tumor progression. We here report that a novel inhibitory anti-asTF monoclonal antibody curtails experimental PDAC progression. Moreover, we show that tumor-derived asTF is able to promote PDAC primary growth and spread during early as well as later stages of the disease. This raises the likelihood that asTF may comprise a viable target in early- and late-stage PDAC. In addition, we show that TF expressed by host cells plays a significant role in PDAC spread. Together, our data demonstrate that targeting asTF in PDAC is a novel strategy to stem PDAC progression and spread.
![Creative Commons License](/images/80x15.png)
PII: 7955